Trichostatin A (TSA) [58880-19-6]

Cat# A8183-5mg

Size : 5mg

Brand : APExBIO Technology

Contact local distributor :


Phone : +1 850 650 7790

Trichostatin A (TSA)

Catalog No.
A8183
HDAC inhibitor

Background

Trichostatin A (TSA, CAS 58880-19-6) is a histone deacetylase (HDAC) inhibitor and antifungal antibiotic isolated from microbial sources. TSA acts by reversibly inhibiting HDAC enzymes in a noncompetitive manner, leading to increased acetylation of histones, particularly histone H4. In mammalian cell cultures, TSA treatment results in G1 and G2 phase arrest, induction of differentiation, and reversion of transformed cellular phenotypes. In human breast cancer cell lines, TSA inhibits proliferation (IC50 = 124.4 ± 120.4 nM) and induces hyperacetylation of histone proteins, highlighting its utility as a tool compound for investigating epigenetic regulation and oncology-related mechanisms.

Reference

David M. Vigushin, Simak Ali, Paul E. Pace, Nina Mirsaidi, Kazuhiro Ito, Ian Adcock, and R. Charles Coombes. Trichostatin A is a histone deacetylase inhibitor with potent antitumot activity against breast cancer in vivo. Clin Cancer Res 2001;7:971-976

Product Citation

Chemical Properties

StorageDesiccate at -20°C
M.Wt302.37
Cas No.58880-19-6
FormulaC17H22N2O3
SynonymsTrichostatin A,TSA
Solubilityinsoluble in H2O; ≥15.12 mg/mL in DMSO; ≥16.56 mg/mL in EtOH with ultrasonic
Chemical Name(2E,4E,6R)-7-[4-(dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxohepta-2,4-dienamide
Canonical SMILESC[C@H](/C=C(\C)/C=C/C(NO)=O)C(c(cc1)ccc1N(C)C)=O
Shipping ConditionSmall Molecules with Blue Ice, Modified Nucleotides with Dry Ice.
General tips We do not recommend long-term storage for the solution, please use it up soon.

Protocol

Cell experiment[1]:

Cell lines

Human breast cancer cell line

Preparation method

The solubility of this compound in DMSO is

Reaction Conditions

10 μM TSA solved in growth medium containing 0.1% (v/v) ethanol for 96 h incubation

Applications

TSA inhibited proliferation of eight breast carcinoma cell lines with mean ± SD IC50 of 124.4 ± 120.4 nM (range, 26.4–308.1 nM). TSA treatment resulted in pronounced histone H4 hyperacetylation.

Animal experiment [1]:

Animal models

Inbred virgin female (Ludwig/Wistar/Olac) rats bearing tumors induced with NMU

Dosage form

500 μg/kg by injection daily for 4 weeks

Applications

TSA had pronounced antitumor activity in vivo. that The antitumor activity of TSA attributabled to induction of differentiation.

Other notes

Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal.

References:

1. Vigushin DM1, Ali S, Pace PE et al. Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. Clin Cancer Res. 2001 Apr;7(4):971-6.

Biological Activity

Targets HDAC          
IC50 ~1.8 nM          

Quality Control

Quality Control & MSDS

View current batch:

Chemical structure

Related Biological Data

Related Biological Data

Related Biological Data

Related Biological Data

Related Biological Data

Related Biological Data

Related Biological Data

 

User Guide

You might also be interested by the following products:



Cat#
Description
Cond.
Price Bef. VAT
SB0838-25g
 25g